Effects of morphine on pain-elicited and pain-suppressed behavior in CB1 knockout and wildtype mice
- 4 March 2011
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 215 (3) , 455-465
Abstract
Rationale Pharmacological manipulations of the type 1 cannabinoid receptor (CB1) suggest a role for CB1 in morphine-induced antinociception, but studies utilizing CB1 knockout (KO) mice do not support this conclusion. Since studies using CB1 KO mice to study morphine’s antinociceptive effects have only examined thermal nociception, this study examines these interactions in models that employ a chemical stimulus. Objectives To determine whether the findings obtained with thermal pain models extend to other models, the effects of morphine on acetic acid-induced writhing were examined in CB1 KO and wildtype (WT) mice. Behaviors that decrease in response to acid injection, feeding and wheel running, were also examined, and investigations were carried out in the thermal hotplate assay. The CB1 antagonist SR141716A was also examined in these assays. Results Morphine completely blocked acid-induced writhing (1.0–10.0 mg/kg) and increased response latencies in the hotplate (10.0–32.0 mg/kg) in both genotypes. Morphine (3.2 mg/kg) significantly attenuated the suppression of wheel running but did not completely prevent this effect in either genotype. Morphine did not alter pain-suppressed feeding. In each of these assays, morphine’s effects were not altered in CB1 KO mice compared with WT mice; however, SR141716A attenuated morphine’s effects in C57BL/6 mice. Conclusions The effects of morphine do not differ in CB1 KO and WT mice in preclinical pain models using thermal and chemical stimuli. Since SR141716A did attenuate the effects of morphine, it is possible that CB1 KO mice undergo developmental changes that mask the role of CB1 receptors in morphine’s antinociceptive effects.Keywords
This publication has 49 references indexed in Scilit:
- Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in ratsPsychopharmacology, 2010
- Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociceptionDrug and Alcohol Dependence, 2009
- Central antinociception induced by µ‐opioid receptor agonist morphine, but not δ‐ or κ‐, is mediated by cannabinoid CB1receptorBritish Journal of Pharmacology, 2009
- The Effects of Repeated Opioid Administration on Locomotor Activity: I. Opposing Actions of μ and κ ReceptorsThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: Drug effects on acetic acid-depressed locomotor activity in ICR miceLife Sciences, 2009
- Effects of pain- and analgesia-related manipulations on intracranial self-stimulation in rats: Further studies on pain-depressed behaviorPain, 2009
- Synergy between Enzyme Inhibitors of Fatty Acid Amide Hydrolase and Cyclooxygenase in Visceral NociceptionThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Mechanisms of Withdrawal-Associated Increases in Heroin Self-Administration: Pharmacologic Modulation of Heroin vs Food Choice in Heroin-Dependent Rhesus MonkeysNeuropsychopharmacology, 2008
- The μ‐opioid receptor agonist morphine, but not agonists at δ‐ or κ‐opioid receptors, induces peripheral antinociception mediated by cannabinoid receptorsBritish Journal of Pharmacology, 2008
- Blockade of THC-Seeking Behavior and Relapse in Monkeys by the Cannabinoid CB1-Receptor Antagonist RimonabantNeuropsychopharmacology, 2008